Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

NCT02265913 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4076

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Labialis

Interventions

DRUG: Acyclovir 5 percent (Perrigo)
DRUG: Acyclovir 5 percent (Reference)
DRUG: Placebo cream

Sponsor

Padagis LLC